Navigation Links
Lexicon Announces Proposed $95 Million Common Stock Offering
Date:3/8/2010

160;Words such as "will," "intends" and similar expressions are intended to identify these forward-looking statements.  There are a number of important factors that could cause Lexicon's results to differ materially from those indicated by these forward-looking statements, including risks and uncertainties related to market conditions and the satisfaction of customary closing conditions related to the proposed public offering.  There can be no assurance that Lexicon will be able to complete the proposed public offering on the anticipated terms, or at all.  Additional risks and uncertainties relating to the proposed public offering, Lexicon and its business can be found under the headings "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission, and under the heading "Risk Factors" in the preliminary prospectus supplement related to the proposed public offering to be filed with the Securities and Exchange Commission on March 8, 2010. Unless required by applicable law, Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Lexicon Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.lexpharma.com

'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
2. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
3. Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
4. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
5. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
6. Lexicon Announces Completion of Public Offering of Common Stock
7. Lexicon Announces Pricing of Common Stock in Public Offering
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
11. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
(Date:1/15/2014)... Jan. 15, 2014 The Cadence Fitness & Health ... by the Medical Fitness Association, a non-profit organization assisting ... full potential. The Cadence Fitness & Health Center is ... and second in the Chicagoland area. "The ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... ANGN ) today reported financial results for its ... Fourth Quarter Highlights: , Revenues ... sequentially up 22% from the third quarter; , Service ... last year,s fourth quarter; , GPO (group purchasing organization) ...
... BEDFORD, Mass., Dec. 15, 2011  Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostic ... to serving the healthcare needs of women, announced ... (FDA) has approved its Cervista HTA (high throughput ...
Cached Medicine Technology:Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 2Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 3Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 4Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 5Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 6Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 7Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 8Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 9Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 10Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 11Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 12FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 2FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 3FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 4
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary research ... Kenis in the Institute of Genomic Biology (IGB) ... Urbana-Champaign describe their recent work on subcellular redox ... cell functions including energy metabolism, signaling, and transcriptional ... normal cellular behavior, redox status has been recognized ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2
... Alan Mozes HealthDay Reporter , THURSDAY, June 16 ... habits of America,s teens, new data from the U.S. Centers ... Not only are high school kids guzzling far too ... CDC research team found. In fact, just one in ...
... A team of social scientists and medical and nursing ... has pinpointed how a programme, which ran in more ... reduced the rates of potentially deadly central line bloodstream ... patient safety programmes. Funded in part by the ...
... MD Diabetes leaders today are responding to the ... (FDA) yesterday that the use of the diabetes medication ... associated with an increased risk of bladder cancer. According ... will be added to the Warnings and Precautions section ...
... quantify causes of death across a population has evolved ... such as heart attack and cancer, the role of ... quantified in the 1990s. More recent research has ... to U.S. mortality. In the first comprehensive analysis of ...
... at Oregon State University has confirmed that an electronic ... to an ambitious goal in the future of medicine ... networks would offer continuous, real-time health diagnosis, experts say, ... and cut health care costs. Some remote health ...
... THURSDAY, June 16 (HealthDay News) -- The quit-smoking drug ... of heart problems in people with cardiovascular disease, the ... In a study of 700 smokers with cardiovascular disease ... researchers saw a small but "statistically significant" greater risk ...
Cached Medicine News:Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 3Health News:International team works out secrets of one of world's most successful patient safety programs 2Health News:International team works out secrets of one of world's most successful patient safety programs 3Health News:Medical societies respond to the FDA's safety announcement on the use of Actos 2Health News:How many US deaths are caused by poverty, low levels of education and other social factors? 2Health News:'Ultrawideband' could be future of medical monitoring 2Health News:Smoking-Cessation Drug Chantix Linked to Heart Problems 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: